RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,468 | +8.8% | 12,792 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $28,910 | -35.2% | 12,792 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $44,644 | -99.6% | 12,792 | -95.3% | 0.00% | -99.6% |
| Q3 2022 | $10,106,000 | +612.7% | 273,000 | +265.5% | 0.25% | +581.1% |
| Q2 2022 | $1,418,000 | -23.4% | 74,700 | +29.1% | 0.04% | -37.3% |
| Q2 2021 | $1,852,000 | +58.4% | 57,853 | +74.2% | 0.06% | +34.1% |
| Q1 2021 | $1,169,000 | – | 33,211 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |